Literature DB >> 26796773

Analysis of Dual Mobility Liner Rim Damage Using Retrieved Components and Cadaver Models.

Audrey K Nebergall1, Andrew A Freiberg1, Meridith E Greene1, Henrik Malchau1, Orhun Muratoglu1, Shannon Rowell1, Thomas Zumbrunn1, Kartik M Varadarajan1.   

Abstract

BACKGROUND: The objective of this study was to assess the retentive rim of retrieved dual mobility liners for visible evidence of deformation from femoral neck contact and to use cadaver models to determine if anterior soft tissue impingement could contribute to such deformation.
METHODS: Fifteen surgically retrieved polyethylene liners were assessed for evidence of rim deformation. The average time in vivo was 31.4 months, and all patients were revised for reasons other than intraprosthetic dislocation. Liner interaction with the iliopsoas was studied visually and with fluoroscopy in cadaver specimens using a dual mobility system different than the retrieval study. For fluoroscopic visualization, a metal wire was sutured to the iliopsoas and wires were also embedded into grooves on the outer surface of the liner and the inner head.
RESULTS: All retrievals showed evidence of femoral neck contact. The cadaver experiments showed that liner motion was impeded by impingement with the iliopsoas tendon in low flexion angles. When observing the hip during maximum hyperextension, 0°, 15°, and 30° of flexion, there was noticeable tenting of the iliopsoas caused by impingement with the liner.
CONCLUSION: Liner rim deformation resulting from contact with the femoral neck likely begins during early in vivo function. The presence of deformation is indicative of a mechanism inhibiting mobility of the liner. The cadaver studies showed that liner motion could be impeded because of its impingement with the iliopsoas. Such soft tissue impingement may be one mechanism by which liner motion is routinely inhibited, which can result in load transfer from the neck to the rim.
Copyright © 2015 Elsevier Inc. All rights reserved.

Entities:  

Keywords:  cadavers; dual mobility; intraprosthetic dislocation; retrievals; total hip arthroplasty

Mesh:

Substances:

Year:  2015        PMID: 26796773     DOI: 10.1016/j.arth.2015.12.032

Source DB:  PubMed          Journal:  J Arthroplasty        ISSN: 0883-5403            Impact factor:   4.757


  6 in total

Review 1.  The evolution of outcomes and indications for the dual-mobility cup: a systematic review.

Authors:  Cécile Batailler; Camdon Fary; Régis Verdier; Thierry Aslanian; Jacques Caton; Sebastien Lustig
Journal:  Int Orthop       Date:  2016-12-21       Impact factor: 3.075

2.  Retrieval evidence of impingement at the third articulation in contemporary dual mobility cups for total hip arthroplasty.

Authors:  Anna Di Laura; Harry S Hothi; Johann Henckel; Arianna Cerquiglini; Ming Han Lincoln Liow; Young-Min Kwon; John A Skinner; Alister J Hart
Journal:  Int Orthop       Date:  2017-06-04       Impact factor: 3.075

3.  Early outcomes of a novel bicruciate-retaining knee system: a 2-year minimum retrospective cohort study.

Authors:  Vivek Singh; David Yeroushalmi; Thomas H Christensen; Thomas Bieganowski; Alex Tang; Ran Schwarzkopf
Journal:  Arch Orthop Trauma Surg       Date:  2022-01-18       Impact factor: 3.067

4.  Reply to Letter to the Editor: Is Isolated Mobile Component Exchange an Option in the Management of Intraprosthetic Dislocation of a Dual Mobility Cup?

Authors:  Julien Wegrzyn; Vincent Pibarot; Gaetano Anania; Jacques Béjui-Hugues
Journal:  Clin Orthop Relat Res       Date:  2020-06       Impact factor: 4.755

5.  Which femoral neck for a dual mobility cup? A biomechanical evaluation.

Authors:  Julien Wegrzyn; Jason Longaray; Rafael Baez; Lizeth Herrera
Journal:  Int Orthop       Date:  2022-05-16       Impact factor: 3.479

6.  Is Isolated Mobile Component Exchange an Option in the Management of Intraprosthetic Dislocation of a Dual Mobility Cup?

Authors:  Julien Wegrzyn; Matthieu Malatray; Vincent Pibarot; Gaetano Anania; Jacques Béjui-Hugues
Journal:  Clin Orthop Relat Res       Date:  2020-02       Impact factor: 4.755

  6 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.